Arrhythmias & electrophysiology

Safety and performance of a novel defibrillation lead for left bundle branch area placement: Primary results of the LEADR left bundle branch area pacing (LBBAP) clinical trial

Heart RhythmPublished clinical trial

Authors' conclusion

These results demonstrate that implantation of OmniaSecure lead when intended for LBBAP results in high defibrillation success at implant, stable short-term electrical parameters, and a low rate of OmniaSecure lead-related major complications at 3 months.

Study context

Population
Patients indicated for de novo implantation of a primary or secondary prevention implantable cardioverter-defibrillator or cardiac resynchronization therapy with a defibrillator, with the OmniaSecure defibrillation lead intended for left bundle branch area pacing (LBBAP)patients who underwent an LBBAP implant attempt, 293 successfully implanted per protocol (95.4%)
Participants
307 patients
Outcome
Defibrillation efficacy at implant (primary efficacy objective; prespecified threshold of 88% in ≥160 patients)
Follow-up
At implant
Methodological detailsglobal
  • Global

Main finding

As reported in the abstract

OmniaSecure lead for LBBAP

100%

Primary efficacy objective met; patients defibrillated to protocol
100%

Further findings

Implant success per protocol

Patients successfully implanted per protocol
293 (95.4%)

Electrical parameters · 2.6 ± 2.5 months' follow-up

Stable electrical parameters

Safety

OutcomeValues
Freedom from OmniaSecure lead-related major complications (primary safety endpoint) · 3 months · primary safety endpointOmniaSecure lead for LBBAP 97.9% (95% CI 95.8–100)

Study lead fractures and oversensing adverse events · 2.6 ± 2.5 months' follow-up

Study lead fractures
zero
No oversensing adverse events

Original publication

Safety and performance of a novel defibrillation lead for left bundle branch area placement: Primary results of the LEADR LBBAP clinical trial. Heart Rhythm. Published 17 October 2025. doi:10.1016/j.hrthm.2025.10.028

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.